227 related articles for article (PubMed ID: 18642290)
1. DNA copy number variation and loss of heterozygosity in relation to recurrence of and survival from head and neck squamous cell carcinoma: a review.
Chen Y; Chen C
Head Neck; 2008 Oct; 30(10):1361-83. PubMed ID: 18642290
[TBL] [Abstract][Full Text] [Related]
2. Genome-wide analysis of recurrent copy-number alterations and copy-neutral loss of heterozygosity in head and neck squamous cell carcinoma.
Marescalco MS; Capizzi C; Condorelli DF; Barresi V
J Oral Pathol Med; 2014 Jan; 43(1):20-7. PubMed ID: 23750501
[TBL] [Abstract][Full Text] [Related]
3. Clonal relationship of synchronous head and neck cancer and esophageal cancer assessed by single nucleotide polymorphism-based loss of heterozygosity analysis.
Sunpaweravong S; Bunbanjerdsuk S; Pongrujikorn T; Naktang C; Sunpaweravong P; Nitiruangjaras A; Dechaphankul T; Jinawath N
BMC Cancer; 2019 Dec; 19(1):1174. PubMed ID: 31795956
[TBL] [Abstract][Full Text] [Related]
4. Impact of chromosome 14q loss on survival in primary head and neck squamous cell carcinoma.
Lee DJ; Koch WM; Yoo G; Lango M; Reed A; Califano J; Brennan JA; Westra WH; Zahurak M; Sidransky D
Clin Cancer Res; 1997 Apr; 3(4):501-5. PubMed ID: 9815712
[TBL] [Abstract][Full Text] [Related]
5. Loss of heterozygosity at 9p and p53 immunopositivity in surgical margins predict local relapse in head and neck squamous cell carcinoma.
Graveland AP; Golusinski PJ; Buijze M; Douma R; Sons N; Kuik DJ; Bloemena E; Leemans CR; Brakenhoff RH; Braakhuis BJ
Int J Cancer; 2011 Apr; 128(8):1852-9. PubMed ID: 20568113
[TBL] [Abstract][Full Text] [Related]
6. Frequent deletion of ING2 locus at 4q35.1 associates with advanced tumor stage in head and neck squamous cell carcinoma.
Borkosky SS; Gunduz M; Nagatsuka H; Beder LB; Gunduz E; Ali MA; Rodriguez AP; Cilek MZ; Tominaga S; Yamanaka N; Shimizu K; Nagai N
J Cancer Res Clin Oncol; 2009 May; 135(5):703-13. PubMed ID: 18998165
[TBL] [Abstract][Full Text] [Related]
7. Genomic assessments of the frequent loss of heterozygosity region on 8p21.3-p22 in head and neck squamous cell carcinoma.
Ye H; Pungpravat N; Huang BL; Muzio LL; Mariggiò MA; Chen Z; Wong DT; Zhou X
Cancer Genet Cytogenet; 2007 Jul; 176(2):100-6. PubMed ID: 17656251
[TBL] [Abstract][Full Text] [Related]
8. Prognostic implications of loss of heterozygosity at 8p21 and 9p21 in head and neck squamous cell carcinoma.
Coon SW; Savera AT; Zarbo RJ; Benninger MS; Chase GA; Rybicki BA; Van Dyke DL
Int J Cancer; 2004 Aug; 111(2):206-12. PubMed ID: 15197772
[TBL] [Abstract][Full Text] [Related]
9. Loss of heterozygosity in FANCG, FANCF and BRIP1 from head and neck squamous cell carcinoma of the oral cavity.
Türke C; Horn S; Petto C; Labudde D; Lauer G; Wittenburg G
Int J Oncol; 2017 Jun; 50(6):2207-2220. PubMed ID: 28440438
[TBL] [Abstract][Full Text] [Related]
10. Loss of heterozygosity on chromosome 2q: possibly a poor prognostic factor in head and neck cancer.
Ransom DT; Barnett TC; Bot J; de Boer B; Metcalf C; Davidson JA; Turbett GR
Head Neck; 1998 Aug; 20(5):404-10. PubMed ID: 9663668
[TBL] [Abstract][Full Text] [Related]
11. Allelotype of squamous cell carcinoma of the head and neck: fractional allele loss correlates with survival.
Field JK; Kiaris H; Risk JM; Tsiriyotis C; Adamson R; Zoumpourlis V; Rowley H; Taylor K; Whittaker J; Howard P
Br J Cancer; 1995 Nov; 72(5):1180-8. PubMed ID: 7577465
[TBL] [Abstract][Full Text] [Related]
12. KLF6 allelic loss is associated with tumor recurrence and markedly decreased survival in head and neck squamous cell carcinoma.
Teixeira MS; Camacho-Vanegas O; Fernandez Y; Narla G; DiFeo A; Lee B; Kalir T; Friedman SL; Schlecht NF; Genden EM; Urken M; Brandwein-Gensler M; Martignetti JA
Int J Cancer; 2007 Nov; 121(9):1976-1983. PubMed ID: 17621627
[TBL] [Abstract][Full Text] [Related]
13. Tumor-related markers in histologically normal margins correlate with locally recurrent oral squamous cell carcinoma: a retrospective study.
Wang X; Chen S; Chen X; Zhang C; Liang X
J Oral Pathol Med; 2016 Feb; 45(2):83-8. PubMed ID: 26260282
[TBL] [Abstract][Full Text] [Related]
14. High level of chromosome 15 aneuploidy in head and neck squamous cell carcinoma lesions identified by FISH analysis: limited value of beta2-microglobulin LOH analysis.
Koene GJ; Arts-Hilkes YH; van der Ven KJ; Rozemuller EH; Slootweg PJ; de Weger RA; Tilanus MG
Tissue Antigens; 2004 Oct; 64(4):452-61. PubMed ID: 15361122
[TBL] [Abstract][Full Text] [Related]
15. Genome wide analysis of DNA copy number neutral loss of heterozygosity (CNNLOH) and its relation to gene expression in esophageal squamous cell carcinoma.
Hu N; Clifford RJ; Yang HH; Wang C; Goldstein AM; Ding T; Taylor PR; Lee MP
BMC Genomics; 2010 Oct; 11():576. PubMed ID: 20955586
[TBL] [Abstract][Full Text] [Related]
16. Aberration of FHIT gene is associated with increased tumor proliferation and decreased apoptosis-clinical evidence in lung and head and neck carcinomas.
Pavelić K; Krizanac S; Cacev T; Hadzija MP; Radosević S; Crnić I; Levanat S; Kapitanović S
Mol Med; 2001 Jul; 7(7):442-53. PubMed ID: 11683369
[TBL] [Abstract][Full Text] [Related]
17. Head and neck cancer in young adults and nonsmokers: study of cancer susceptibility by genome-wide high-density SNP microarray mapping.
Pfeiffer J; Wiech T; Maier W; Ridder GJ; Laszig R; Birkenhäger R
Acta Otolaryngol; 2011 Oct; 131(10):1091-8. PubMed ID: 21631177
[TBL] [Abstract][Full Text] [Related]
18. Multiple tumor-suppressor genes on chromosome 3p contribute to head and neck squamous cell carcinoma tumorigenesis.
Lee DJ; Schönleben F; Banuchi VE; Qiu W; Close LG; Assaad AM; Su GH
Cancer Biol Ther; 2010 Oct; 10(7):689-93. PubMed ID: 20657180
[TBL] [Abstract][Full Text] [Related]
19. Molecular predictors of clinical outcome in patients with head and neck squamous cell carcinoma.
Thomas GR; Nadiminti H; Regalado J
Int J Exp Pathol; 2005 Dec; 86(6):347-63. PubMed ID: 16309541
[TBL] [Abstract][Full Text] [Related]
20. 9p21 deletion correlates with recurrence in head and neck cancer.
Lydiatt WM; Davidson BJ; Schantz SP; Caruana S; Chaganti RS
Head Neck; 1998 Mar; 20(2):113-8. PubMed ID: 9484941
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]